Leaderboards/diet metabolism and disease

diet metabolism and disease

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Haiyuan Shen
Unknown
99
2
Shi Yin
Unknown
90
3
Nick Quinn-Bohmann
University of Washington
80
4
Sean M. Gibbons
University of Washington
70
5
Fabian Eichelmann
Deutsches Diabetes-Zentrum e.V.
60
6
Clemens Wittenbecher
Science for Life Laboratory
50
7
Junhong Qin
Sichuan University
20

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Ipsita Mohanty
University of California San Diego
99
2
Yu-Ling Xiao
Shanghai Medical College of Fudan University
80
3
Chang Liu
Shandong University
70
4
Hu Wang
Peking University
60
5
Jing Zhong
Huzhou University
50
6
Panu K. Luukkonen
University of Helsinki
40
7
Yujia Xia
The Ohio State University Wexner Medical Center
30
8
Suowen Xu
University of Science and Technology of China
20
9
Gopal Lamichhane
Oklahoma State University
10

Emerging Leaders Papers

1
Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling
Nature Communications|2023
119 cit.
2
Inhibition of <i>HSD17B13</i> protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
Proceedings of the National Academy of Sciences|2023
54 cit.
3
Curcumin Mitigates Gut Dysbiosis and Enhances Gut Barrier Function to Alleviate Metabolic Dysfunction in Obese, Aged Mice
Biology|2024
15 cit.
4
A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY
Theranostics|2025
12 cit.
5
Curcumin-Rich Diet Mitigates Non-Alcoholic Fatty Liver Disease (NAFLD) by Attenuating Fat Accumulation and Improving Insulin Sensitivity in Aged Female Mice under Nutritional Stress
Biology|2024
6 cit.
6
&lt;b&gt;Identification of BAF60b as a chromatin remodeling checkpoint of diet-induced fatty liver disease&lt;/b&gt;
Unknown Journal|2024
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Hong Chen
Novartis (China)
99
2
Paolo Lionetti
Meyer Children's Hospital
90
3
Stanley L. Hazen
Cleveland Clinic
80
4
Charles R. Mackay
Cooperative Trials Group for Neuro-Oncology
70
5
Fredrik Bäckhed
Novo Nordisk Foundation
60
6
John C. Lindon
Imperial College London
50
7
Brett P. Monia
Ionis Pharmaceuticals (United States)
40
8
Séverine Layec
Microbiologie de l’alimentation au service de la santé
20

All-Time Leaders Papers

1
Gut Microbiota in Cardiovascular Health and Disease
Circulation Research|2017
1.6k cit.
2
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Journal of Clinical Investigation|1997
843 cit.
3
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
Journal of Clinical Investigation|2004
647 cit.
4
CXCR5 Expressing Human Central Memory CD4 T Cells and Their Relevance for Humoral Immune Responses
The Journal of Immunology|2011
316 cit.
5
Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle
Journal of Biological Chemistry|2009
266 cit.
6
The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects
Journal of Biological Chemistry|2013
241 cit.
7
Dietary Fiber and Microbiota Metabolite Receptors Enhance Cognition and Alleviate Disease in the 5xFAD Mouse Model of Alzheimer’s Disease
Journal of Neuroscience|2023
69 cit.
8
PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome
Proceedings of the National Academy of Sciences|2016
48 cit.
9
Iron supplementation and iron accumulation promote adipocyte thermogenesis through PGC1α-ATGL–mediated lipolysis
Journal of Biological Chemistry|2024
10 cit.

Indexing diet metabolism and disease Reagents

Citation data for reagents in this field is currently compiling.